Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2002
10/10/2002WO2002079139A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002WO2002079137A1 Interleukin-1 and tumor necrosis factor-alpha modulators and their enantiomers, their synthesis and use
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078742A2 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002WO2002078741A2 Methods and compositions for modulating the immune system of animals
10/10/2002WO2002078736A2 Antiallergic pharmaceutical composition
10/10/2002WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002WO2002078731A1 Module of pd-1 interactions with its ligands
10/10/2002WO2002078720A2 Antibiotics from bacteria isolated from amphibian skin
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002WO2002078684A2 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078637A2 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
10/10/2002WO2002078624A2 Aerosol administration of interleukin-2 liposomes
10/10/2002WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002WO2002078599A2 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
10/10/2002WO2002062795A9 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002058636A3 Novel cannabimimetic ligands
10/10/2002WO2002032450A3 Vaccines
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002028429A3 Modulation of allergic response
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002015915A3 Method for inducing an anti-tumor and anti-cachexia immune response in mammals
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002002172A3 Dna palindrome - oligoguanylic acid compositions and uses thereof
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001074382A9 Method of treatment using ligand-immunogen conjugates
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147344 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147233 Epoxyvibsanin B
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147201 Glycyrrhizin complex
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147189 Immunology response; autoimmune disease
10/10/2002US20020147181 Viricides
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147130 Treatment of hiv
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146683 Modified hiv env polypeptides
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002US20020146431 For prophylaxis of porcine multisystemic wasting syndrome (PMWS)
10/10/2002US20020146429 Live vaccines for allergy treatment
10/10/2002US20020146426 Administering molecule joined to a heat shock protein or molecule joined to an adenosinetriphosphate (ATP) binding domain of a heat shock protein inducing an immune response that includes a CD8+ cytotoxic T lymphocyte (CTL) response
10/10/2002US20020146422 For therapy of asthma; allergies to pollen, fur, and/or house dust; various food allergies; and various forms of eczema
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002DE10115310A1 Bakteriophagen-Präparation Bacteriophage preparation
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442457A1 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002CA2442106A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2440831A1 Combination therapy using cd40 and cd20 ligands
10/10/2002CA2440249A1 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2437099A1 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002CA2437095A1 Methods and compositions for modulating the immune system of animals
10/10/2002CA2433910A1 Antibiotics from bacteria isolated from amphibian skin
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247529A1 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs
10/09/2002EP1247103A2 Tethered ligands and methods of use
10/09/2002EP1246940A2 Chemotherapeutant screening method
10/09/2002EP1246929A2 Methods and compositions for obtaining disease protection for animals
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246901A1 Methods for protein transfer
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
1 ... 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 ... 1172